Survey of the temporal changes in HIV-1 replicative fitness in the Amsterdam Cohort (Q39015854)

8 September 2017

Survey of the temporal changes in HIV-1 replicative fitness in the Amsterdam Cohort (English)

1 reference

8 September 2017

1 reference

4

Margreet Bakker

1 reference

8 September 2017

2

Ben Berkhout

1 reference

8 September 2017

5

Nicole K T Back

1 reference

8 September 2017

Youssef Gali

1

1 reference

8 September 2017

Guido Vanham

series ordinal

3

1 reference

8 September 2017

Kevin K Ariën

series ordinal

6

1 reference

8 September 2017

language of work or name

English

0 references

publication date

28 March 2007

1 reference

8 September 2017

1 reference

8 September 2017

364

1 reference

8 September 2017

1

1 reference

8 September 2017

140-146

1 reference

The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates

8 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

Replicative fitness of CCR5-using and CXCR4-using human immunodeficiency virus type 1 biological clones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

Design and evaluation of an in-house HIV-1 (group M and O), SIVmnd and SIVcpz antigen capture assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

Fitness of RNA virus decreased by Muller's ratchet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

The red queen reigns in the kingdom of RNA viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

Rapid fitness losses in mammalian RNA virus clones due to Muller's ratchet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

Genetic lesions associated with Muller's ratchet in an RNA virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

Human immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02_AG (CRF02_AG) has a higher in vitro replicative capacity than its parental subtypes A and G.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

Recent evolutionary history of human immunodeficiency virus type 1 subtype B: reconstruction of epidemic onset based on sequence distances to the common ancestor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

THE RELATION OF RECOMBINATION TO MUTATIONAL ADVANCE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

Stable virulence levels in the HIV epidemic of Switzerland over two decades

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

Is HIV-1 evolving to a less virulent (pathogenic) virus?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

The host environment drives HIV-1 fitness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

Molecular evolution as predicted by natural selection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

Diminished replicative fitness of primary human immunodeficiency virus type 1 isolates harboring the K65R mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

inferred from DOI database lookup

7 January 2021

based on heuristic

Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

inferred from DOI database lookup

7 January 2021

based on heuristic

Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.021

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2007.02.021

1 reference

8 September 2017

1 reference